|
ENCANTO introduces an innovative regenerative treatment for patellofemoral (knee-cap) osteoarthritis (PFOA) based on biological cartilage grafts engineered from nasal cartilage cells (chondrocytes), named N-TEC (Nasal chondrocyte Tissue Engineered Cartilage).
|
|
|
ENCANTO (ENgineered CArtilage from Nose for the Treatment of Osteoarthritis) is an international multicenter randomized clinical phase II study on knee-cap osteoarthritis.
|
|
|
This therapy is expected to regenerate the cartilage tissue, sustainably restore joint homeostasis, reduce pain, improve mobility and thereby enable an active life for young and elderly patients.
|
|
|
Find out more at ENCANTO official website.
|
